The blue social bookmark and publication sharing system.
Log in with your username.
I've lost my password.
Log in with your OpenID-Provider.
The anti-inflammatory potential of an oral p38 MAPK inhibitor in humans in vivo suggests that p38 MAPK inhibitors may provide a new therapeutic option in the treatment of inflammatory diseases. Boehringer Ingelheim. 2002 Branger J, et al